Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Income from Continuing Operations (2019 - 2025)

Historic Income from Continuing Operations for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to -$18.1 million.

  • Korro Bio's Income from Continuing Operations rose 1399.11% to -$18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$88.5 million, marking a year-over-year decrease of 76.19%. This contributed to the annual value of -$83.6 million for FY2024, which is 304.17% down from last year.
  • Latest data reveals that Korro Bio reported Income from Continuing Operations of -$18.1 million as of Q3 2025, which was up 1399.11% from -$25.8 million recorded in Q2 2025.
  • In the past 5 years, Korro Bio's Income from Continuing Operations registered a high of $6.2 million during Q4 2022, and its lowest value of -$25.8 million during Q2 2025.
  • For the 5-year period, Korro Bio's Income from Continuing Operations averaged around -$19.7 million, with its median value being -$21.0 million (2024).
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first soared by 12877.21% in 2022, then crashed by 51102.49% in 2023.
  • Quarter analysis of 5 years shows Korro Bio's Income from Continuing Operations stood at -$21.5 million in 2021, then skyrocketed by 128.77% to $6.2 million in 2022, then tumbled by 511.02% to -$25.4 million in 2023, then rose by 16.39% to -$21.3 million in 2024, then increased by 15.04% to -$18.1 million in 2025.
  • Its last three reported values are -$18.1 million in Q3 2025, -$25.8 million for Q2 2025, and -$23.4 million during Q1 2025.